Burden of Disease and Cost of Chronic Hepatitis C Virus Infection in Canada

Although the prevalence of HCV in Canada is decreasing, cases of advanced liver disease and health care costs continue to rise. These results will facilitate disease forecasting, resource planning and the development of rational management strategies for HCV in Canada.